Follow the latest coverage, related explainers and connected technology stories.
ARPA-H has awarded more than $100 million to four entities developing wearable devices to monitor indicators of heart failure, inflammation, and perimenopausal transitions. The program relies on designs that can integrate multiple sensors, with testing stages including in-body prototypes and clinical trials.